Clinical Trial Update: Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH) [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 study of ACT-293987 (NS-304) for Pulmonary arterial hypertension conducted by Actelion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• ACT-293987 (NS-304)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED